{Reference Type}: Journal Article
{Title}: Continued Success of Venetoclax in t(11;14) Multiple Myeloma Despite Negative Trials.
{Author}: Avigan ZM;Joshua Richter Md ;
{Journal}: Oncology (Williston Park)
{Volume}: 38
{Issue}: 6
{Year}: 2024 06 10
{Factor}: 2.533
{DOI}: 10.46883/2024.25921023
{Abstract}: The June Hot Topics focuses on the challenges venetoclax regimens have faced in multiple myeloma trials.